Sort
17,288 grants matching “multiple sclerosis”
Signal Transduction to p70 S6 Kinase 1
$575,424John Blenis · Harvard Medical School · R01 · FY2008 · GM
ICLIC-MS for Enhancing Outcomes Research and Clinical Care in Multiple Sclerosis
$575,200Lisa F Barcellos · University Of California Berkeley · R01 · FY2020 · NR
Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)
$575,094David C Hess · Augusta University · R01 · FY2007 · NS
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$575,015Michael R Wilson · University Of California, San Francisco · R01 · FY2024 · NS
Mechanisms underlying Sex differences in Cerebral Amyloid Angiopathy: The Fibrin-Microglia Crosstalk
$574,905Bharti Manwani · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$574,829Emmanuel J Mignot · Stanford University · U01 · FY2025 · NS
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease
$574,654Stelios Theoharis Andreadis · State University Of New York At Buffalo · R01 · FY2025 · NS
Advanced Statistical Analytics of MRI in MS
$574,647Russell Takeshi Shinohara · University Of Pennsylvania · R01 · FY2021 · NS
From Research to Clinic: Addressing Ethical and Policy Challenges Facing the Gene Therapy Ecosystem
$574,582Karen Joann Maschke · Hastings Center, Inc. · R01 · FY2024 · HG
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
$574,568Alberto Ascherio · Harvard School Of Public Health · R01 · FY2014 · NS
Toward a Validated in Vivo Imaging Marker of Axonal Damage Predictive of Progressive Disability in Multiple Sclerosis
$574,435Susie Yi Huang · Massachusetts General Hospital · R01 · FY2025 · NS
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology
$574,350Cheemeng Tan · University Of California At Davis · R01 · FY2025 · EB
Interdisciplinary Immunology Training Program
$573,951Yale University · T32 · FY2005 · AI
Identification of Regulatory Mechanisms Operating in Rare Pathogenic Astrocyte Subsets in Multiple Sclerosis with a Novel Genomic Technology
$573,663Adam R. Abate · University Of California, San Francisco · R01 · FY2025 · NS
Toward a Validated in Vivo Imaging Marker of Axonal Damage Predictive of Progressive Disability in Multiple Sclerosis
$573,548Susie Yi Huang · Massachusetts General Hospital · R01 · FY2023 · NS
Blood Brain Barrier Changes Induced by Pain
$573,516Thomas Paul Davis · University Of Arizona · R01 · FY2008 · NS
Interdisciplinary Immunology Training Program
$573,501Yale University · T32 · FY2004 · AI
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology
$573,422Adam R. Abate · University Of California, San Francisco · R01 · FY2023 · NS
White Matter Abnormalities in Schizophrenia
$573,362Kelvin O. Lim · University Of Minnesota · R01 · FY2009 · MH
Regulation and Evolution of Alternative mRNA Isoform Expression in Mammals
$573,238Christopher B Burge · Massachusetts Institute Of Technology · R01 · FY2011 · HG
Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondyilitis
$573,118Xiaodong Zhou · University Of Texas Hlth Sci Ctr Houston · U01 · FY2010 · AI
Histone Deacetylation in Oligodendrocyte Differentiation
$572,955Patrizia Casaccia · Icahn School Of Medicine At Mount Sinai · R37 · FY2014 · NS
No-Gd MRI for Monitoring Disease Status in Multiple Sclerosis
$572,878Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · NS
Novel Strategies to Identify GxE Contributions to MS Pathogenesis
$572,704Lisa F Barcellos · University Of California Berkeley · R01 · FY2015 · ES
Blood Brain Barrier Changes Induced by Pain
$572,694Thomas Paul Davis · University Of Arizona · R01 · FY2012 · NS